Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China

We performed a multicenter, prospective, randomized study to investigate the efficacy and safety of clofazimine (CLO) for treatment of extensively drug-resistant tuberculosis (XDR-TB) in China. Forty-nine patients infected with XDR-TB were randomly assigned to either the control group or the CLO gro...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Antimicrob Agents Chemother
Main Authors: Wang, Qingfeng, Pang, Yu, Jing, Wei, Liu, Yufeng, Wang, Na, Yin, Hongyun, Zhang, Qing, Ye, Zhizhong, Zhu, Min, Li, Fujian, Liu, Ping, Wu, Tingting, Chen, Wei, Wu, Wei, Qin, Zhihua, Qiu, Chao, Deng, Qunyi, Xu, Tao, Wang, Jing, Guo, Ru, Du, Yadong, Wang, Jun, Huang, Hairong, Chen, Xiaohong, Chu, Naihui
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2018
נושאים:
Clinical Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913945/
https://ncbi.nlm.nih.gov/pubmed/29378718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02149-17
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים